Joshua Ballard
Analyst · Raymond James
Good afternoon, everyone. I'll start first with providing a few more details on our top line growth. Revenue grew 47% in the third quarter year-on-year, and that has grown 18% year-to-date. The real story within these results is the strength in OEM and aftermarket sales, which are finally broken through our COVID lows in 2020 and 2021. OEM sales, excluding industrial wastewater, have grown over 60% year-to-date and aftermarket has exceeded 30%. These strong results reflect, in part, a backlog of projects that were delayed in the past couple of years. It is likely that 2022 will be our largest year ever in both OEM and aftermarket sales. As I mentioned in prior calls, our mega project revenue started out slow in the first half of the year but is picking up in the second half as expected. While Q3 was a strong quarter, our fourth quarter should be our strongest ever led by mega-project shipments. However, as Bob mentioned, there is some risk in our fourth quarter. I want to be clear that, this risk is simply due to temporary project-specific delays. While we are seeing some changes in the timing of a few individual projects, we are not yet seeing a shift in our longer-term outlook related to global economic events. There were two key project-related shifts this year. First, about $4 million of our 2022 backlog is shifting to Egypt, where local capital controls have been put in place to slow hard currency payments due to a weakening Egyptian pound. This has slowed our ability to ship and recognize this revenue. While the timing is in flux, as of today, we are confident these projects will shift either this year or next. Second, another $6 million project in the UAE was delayed due to the replacement of the EPC itself. This project is being rebid and revenue is likely delayed until 2024. We're working hard to solve these challenges, but there does seem to be more risk to the timing of our 2022 revenue, which is why we've adjusted to a range. In 2023, the dynamics of our desalination revenue will likely change somewhat. First, after a COVID rebound in OEM and aftermarket sales, we expect these channels to remain relatively flat to slightly down in 2023. However, our mega project channel should exhibit growth of 6% to 12%, which shows continued strength in our most important channel for desalination growth. Therefore, in 2023, we are currently projecting overall desalination revenue growth of between 3% to 7%. However, the actual growth rate in 2023 will much depend on our final 2022 results. And so, I will update you again at the next earnings call. This may be slower growth than 2022. However, we often talk about the lumpy nature of our desalination revenue, as a slight shift in the timing of one or two mega projects can have an outsized effect on growth in a given year. This is in part what we are seeing in 2023. You should also note that this growth is overweighted to the latter half of next year due to the timing of these mega project shipments. Our first quarter will likely be our lowest quarter of the year at between $10 million to $15 million in revenue and our second quarter could fall to between $20 million to $25 million with the remaining balance split between Q3 and Q4. We anticipate 2024 to be another strong year for desalination, where revenue growth could again exceed 20%. This growth in 2024 will put us back on an average 15% growth trend and put us well on the path to achieving our $200 million target in desalination revenue by 2026. We believe the secular strength of desalination remains strong. In industrial wastewater, we are targeting $6 million to $8 million in revenue in 2023, which would mean doubling from this year. At least a doubling again of revenue in industrial wastewater in 2024 will keep us on track to hit our target of $30 million to $70 million in 2026. Despite our bullish niche, we are watching global events and in particular, three main risks in the short to medium term, inflation, the strengthening dollar and a potential global economic downturn. The biggest risk to our outlook is in our desalination OEM and aftermarket channels where we have visibility on average of only about six months. These two channels could be more negatively affected by a strengthening dollar, or a potential global economic slowdown because 40% to 50% of their revenue is made up of a variety of industries and as many countries. We are already experiencing a negative effect related to the dollar with our sales in Egypt, as I described earlier. While 60% to 70% of our revenue is currently in the Middle East, where there is little fear as a rising dollar or an economic downturn, it could affect customers in other parts of the world such as North Africa, Asia and Latin America. We are less concerned as to how these economic events could affect our launch in the CO2 business. This is a new business and whether there is a slowdown in the overall industry is largely relevant to us. As the transition to CO2 means that the CO2 market will continue to grow at a very fast clip regardless. In addition, our product helps supermarkets save money, which only becomes more valuable in a challenging inflationary environment. Now let's turn to gross margin. We remain on target to achieve our guidance, 66% to 68% gross margin in 2022 and will likely end the year at the higher end of this range. We still expect to see some softening of our water margin in 2023 as we experience growing wages, hospital increased tariffs and other inflationary pressures. In addition, we are expecting a growing shift in product mix whereas we are providing more integrated packages, including racks and manifolds, which have grown to as high as 4% of revenue this past year. Racks and manifolds are an added service to our customers, but largely a pass-through cost for us at a much reduced margin. Of course, as every company is today, we are looking at pricing and methods to increase manufacturing efficiencies to mitigate the effect of increasing costs. Altogether, we are currently estimating a water gross margin of between 64% to 66% in 2023. Our blended top line gross margin will depend on the level of CO2 sales next year as the nature of our volume sales in the start-up business begin to take shape in 2023, I will be sure to update. Let's now turn to operating expenses. Our OpEx, excluding the one-time expenses associated with seasoning VorTeq operations continues to evolve in line with what I've described in past calls. This year, we are trending to roughly 48% to 49% of revenue based on our original revenue guidance or approximately $63 million to $64 million in OpEx when excluding those one-time expenses. This OpEx range translates in the 50% to 52% of revenue based on our adjusted guidance for this year. You will note that sales and marketing spend represents up to 80% of growth in recurring OpEx in 2022 as we ramp up our CO2 and industrial wastewater teams. Also included is the post-COVID balances spend as our desalination sales team return to traveling, trade shows picked up and so forth. We expect this dynamic will remain much the same in 2023 with lower digital -- with lower single-digit growth in G&A spend, largely driven by wage inflation and headcount added in 2022 along with inflationary increases in insurance and professional services spend such as auto. We expect growth of high 30% to 40% in sales and marketing spend as we accelerate investments in CO2 and industrial wastewater and flat to a possible slight decrease in R&D spend due to the lack of VorTeq investments in 2023. Overall, we expect OpEx as a percent of revenue to come in at 52% to 53% next year. This will be a slight increase over 2022 and we remain steadfast in maintaining our disciplined approach to spend as we grow. Inflation and our need to invest in sales and marketing ahead of future sales has simply caused a bit of a bump. However, I remain confident that by 2026, we can still reduce our operating spend to a lower percent of revenue likely in the 30% to 35% range. In 2024, assuming we achieve the growth we are targeting, we will see the trend of OpEx decreasing as a percent of revenue begin to accelerate. As we look forward to 2024 through 2026, G&A spend should continue to grow at a much slower pace than revenue, and therefore, normalize over this period. Sales and marketing spend will likely remain elevated over the next year or two, but should begin the fall to a more normalized range of 5% to 10% of revenue as we realize revenue for our new business plan. And finally, based on our current strategy, R&D spend should continue to grow slowly and therefore, fall below 10% of revenue in the coming years. What does all this mean for our bottom line profitability? In 2023, we are currently projecting a somewhat weaker operating margin compared to 2022 between 10% to 14% and adjusted EBITDA margin of 19% to 23%. We should see our operating margin begin to grow again in 2024 through 2026. The simple math is this. If we assume an average blended gross margin 60% by 2026 within our three business lines, and reduce our OpEx to 30% to 35%. This implies an operating margin over the long run of 25% to 30%, and therefore, an adjusted EBITDA margin of roughly 35% to 40%. And our projections of net profit, we are assuming a 15% to 20% tax range, which I would use for projections going forward. Let's now turn to cash. Our current cash and security balance remained at a healthy $87 million in Q3, and we believe we will end the year at between $90 million to $100 million. Where we end in that range depends solely on the timing of customers we see at this point. We have clearly made a significant investment in inventory this year. However, this pace will not continue. First, we will ship out a lot of pressure exchanges in the fourth quarter. Second, while you continue to see growth in our raw material inventory levels that will begin to reduce by early 2023. We had two goals this year. We have targeted to end the year with four to five months of pressure exchanger inventory, which is roughly what we ended last year with. Also, we continue to build a raw material inventory in light of production and supply chain issues in both China and Europe, which we believe we can begin to moderate as we head into 2023. As we look forward, we should begin to see a reduction in inventory levels in Q4, which will likely continue throughout the first half of 2023. We will need to be careful to balance our finished good inventory levels with a changing product mix, which includes our new Q400, our industrial wastewater products and the PXG. In addition, we must keep an eye on our capacity needs as we gauge how quickly the CO2 business will ramp up in the latter half of 2023 and into 2024. Increased finished good levels of our stable water products, for example, could help to free up capacity in 2024, if it needed for CO2. In short, we will keep you updated as these businesses evolve next year. We are expecting to invest $4 million to $4.5 million in total CapEx by the end of this year, and likely a similar level in 2023 as we continue to upgrade our manufacturing equipment in San Leandro and in the overall facilities. We do not expect a large increase in CapEx to occur until we begin to see growth in CO2, at which time we will need to invest in new capacity to manage future growth. At this time, there is no plan for additional share buybacks. With that, we can move into Q&A.